Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Outset Medical Inc. On Behalf of Shareholders

Wednesday, 23 October 2024 02:45 PM

WILMINGTON, DE / ACCESSWIRE / October 23, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ GS:OM) on behalf of stockholders.

If you purchased or otherwise acquired Eagle Pharmaceuticals shares on or before September 15, 2020 and want to learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-outset-medical-inc. You may also contact Leah Wihtelin cost free at (516) 693-8926 or by email at [email protected].

About the Investigation:

The investigation concerns whether Outset Medical and certain of its directors and/or officers issued materially misleading information and/or failed to disclose material information to the investing public. Specifically, the investigation concerns whether Outset Medical and certain of its directors and/or officers failed to disclose to shareholders that: (i) TabloCart, an accessory for the Company's flagship product, Tablo Hemodialysis System ("Tablo"), required prior clearance from the FDA for marketing authorization, which would require the Company to halt sales of TabloCart until FDA approval was received; (ii) the Company lacked the sales team and process to ramp up sales of Tablo; (iii) Outset Medical marketed its Tablo products for continual renal replacement therapy as a modality even though it was not included in the FDA-approved indications; and (iv) as a result, the Company's reports and financial statements were not accurate.

There is No Cost to You:

There is no cost to you to join this action. We represent investors on a contingency fee basis. This means that we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees only if we are successful.

About Rigrodsky Law:

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:

Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: [email protected]

SOURCE: Rigrodsky Law

Topic:
Class Action
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: